1. Home
  2. APRE vs CARV Comparison

APRE vs CARV Comparison

Compare APRE & CARV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APRE
  • CARV
  • Stock Information
  • Founded
  • APRE 2006
  • CARV 1948
  • Country
  • APRE United States
  • CARV United States
  • Employees
  • APRE N/A
  • CARV N/A
  • Industry
  • APRE Biotechnology: Biological Products (No Diagnostic Substances)
  • CARV Savings Institutions
  • Sector
  • APRE Health Care
  • CARV Finance
  • Exchange
  • APRE Nasdaq
  • CARV Nasdaq
  • Market Cap
  • APRE 9.4M
  • CARV 9.6M
  • IPO Year
  • APRE 2019
  • CARV 1994
  • Fundamental
  • Price
  • APRE $1.55
  • CARV $2.93
  • Analyst Decision
  • APRE Strong Buy
  • CARV
  • Analyst Count
  • APRE 1
  • CARV 0
  • Target Price
  • APRE $20.00
  • CARV N/A
  • AVG Volume (30 Days)
  • APRE 33.0K
  • CARV 231.5K
  • Earning Date
  • APRE 11-06-2025
  • CARV 08-13-2025
  • Dividend Yield
  • APRE N/A
  • CARV N/A
  • EPS Growth
  • APRE N/A
  • CARV N/A
  • EPS
  • APRE N/A
  • CARV N/A
  • Revenue
  • APRE $841,012.00
  • CARV $22,032,000.00
  • Revenue This Year
  • APRE N/A
  • CARV N/A
  • Revenue Next Year
  • APRE N/A
  • CARV N/A
  • P/E Ratio
  • APRE N/A
  • CARV N/A
  • Revenue Growth
  • APRE N/A
  • CARV N/A
  • 52 Week Low
  • APRE $1.41
  • CARV $1.30
  • 52 Week High
  • APRE $5.01
  • CARV $3.85
  • Technical
  • Relative Strength Index (RSI)
  • APRE 42.03
  • CARV 74.53
  • Support Level
  • APRE $1.49
  • CARV $1.61
  • Resistance Level
  • APRE $1.65
  • CARV $3.85
  • Average True Range (ATR)
  • APRE 0.08
  • CARV 0.33
  • MACD
  • APRE -0.01
  • CARV 0.15
  • Stochastic Oscillator
  • APRE 23.08
  • CARV 58.93

About APRE Aprea Therapeutics Inc. Common stock

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.

About CARV Carver Bancorp Inc.

Carver Bancorp Inc is a holding company and conducts its business as a unitary saving and loan holding firm and the business of the company consists of the operation of its subsidiary. The bank offers a wide range of financial solutions to meet customers' banking. It offers other consumer and commercial banking products and services, such as debit cards, online banking, online bill pay, and telephone banking. The company provides deposit products, such as demand, savings, and time deposits for consumers, businesses, and governmental and quasi-governmental agencies in its market area within New York City.

Share on Social Networks: